companiesCompany
Diakonos Oncology
Diakonos Oncology makes dendritic cell therapies from a patient's own cells, with trials under way in glioblastoma, pancreatic cancer and melanoma.
Overview
Diakonos Oncology develops patient-derived dendritic cell vaccines that present the patient's own tumour antigens to the immune system, and is running clinical trials in glioblastoma, pancreatic cancer and melanoma. Access is through trial enrolment.
Headquarters
United States (city not published), US
Type
cell therapy
Stage
Startup
Website
Similar pages
not linked directly; found by shared links- InstitutionImmunocine
Shares Dendritic cell vaccines and the tag fcct-directory.
- InstitutionCeCurio (MVZ Tübingen oncology)
Shares Glioma & glioblastoma and the tag fcct-directory.
- CompanyBelay Diagnostics
Shares Glioma & glioblastoma and the tag fcct-directory.
- CompanyKiyatec
Shares Glioma & glioblastoma and the tag fcct-directory.
- CompanyMedigene
Shares Dendritic cell vaccines, Pancreatic ductal adenocarcinoma.